|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
What's Wrong with Money In Science?
After this week's controversy surrounding the alleged failure of several authors of a JAMA article to disclose pharmaceutical industry ties, Stossel and Shaywitz provide a counter–argument that private money in medicine doesn't weaken medical research—it strengthens it.
Like other prestigious medical journals, JAMA has become fixated in recent years on commercial conflicts of interest. In the end, however, JAMA seemed willing to apply a looser standard for a consumer activist group that reflects its ideological viewpoint—corporate sponsorship corrupts research—than it does for top scientists and doctors who receive industry funding.
|home spotlight commentary research events news about contact links archives|